Announcement on the Passing of U.S. FDA On-site Inspection of Florfenicol, a Wholly-owned Subsidiary's Product

About this update from Guobang Pharma Ltd. Class A

Announcement on the Passing of U.S. FDA On-site Inspection of Florfenicol, a Wholly-owned Subsidiary's ProductThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Guobang Pharma Ltd. Class A